FPA150 in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer|Endometrial Cancer|Advanced Solid Tumors
Interventions: BIOLOGICAL: FPA150|BIOLOGICAL: Pembrolizumab
Sponsor: Five Prime Therapeutics, Inc.